Clinical trial
McLean and Genomind Prospective Study of Pharmacogenetic Testing
NCT03113890 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- McLean and Genomind Prospective Study of Pharmacogenetic Testing
- Lead sponsor
- Mclean Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 22, 2017
- Completion date
- July 31, 2020
- Enrollment
- 75 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.